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Abstract In patients with iron overload disorders,
increasing number of reports of renal dysfunction and
renal iron deposition support an association between
increased iron exposure and renal injury. In systemic
iron overload, elevated circulating levels of transfer-
rin-bound (TBI) and non-transferrin-bound iron
(NTBI) are filtered to the renal proximal tubules,
where they may cause injury. However, the mecha-
nisms of tubular iron handling remain elusive. To
unravel molecular renal proximal tubular NTBI and
TBI handling, human conditionally immortalized
proximal tubular epithelial cells (ciPTECs) were
incubated with 55Fe as NTBI and fluorescently labeled
holo-transferrin as TBI. Ferrous iron importers ZIP8
and ZIP14 were localized in the ciPTEC plasma
membrane. Whereas silencing of either ZIP8 or ZIP14
alone did not affect 55Fe uptake, combined silencing
significantly reduced 55Fe uptake compared to control
(p\ 0.05). Furthermore, transferrin receptor 1 (TfR1)
and ZIP14, but not ZIP8, colocalized with early
endosome antigen 1 (EEA1). TfR1 and ZIP14 also
colocalized with uptake of fluorescently labeled
transferrin. Furthermore, ZIP14 silencing decreased
55Fe uptake after 55Fe-Transferrin exposure
(p\ 0.05), suggesting ZIP14 could be involved in
early endosomal transport of TBI-derived iron into the
cytosol. Our data suggest that human proximal tubular
epithelial cells take up TBI and NTBI, where ZIP8 and
ZIP14 are both involved in NTBI uptake, but ZIP14,
not ZIP8, mediates TBI-derived iron uptake. This
knowledge provides more insights in the mechanisms
of renal iron handling and suggests that ZIP8 and
ZIP14 could be potential targets for limiting renal iron
reabsorption and enhancing urinary iron excretion in
systemic iron overload disorders.
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Introduction
Iron is an essential element for life, but it can also be
harmful by catalyzing the formation of reactive
oxygen species in the Fenton reaction (Koppenol
1993). The human body is able to regulate iron uptake
and storage, but has limited abilities to regulate iron
excretion (Brissot and Loreal 2016). Therefore,
disturbed intestinal iron uptake in hereditary
hemochromatosis, and frequent red blood cell trans-
fusions in b-thalassemia major, can result in systemic
iron overload and organ damage (Brissot and Loreal
2016). In these disorders, patients present with
increased levels of iron bound to the circulating
transport protein transferrin (transferrin-bound iron;
TBI) (Brissot and Loreal 2016). Once transferrin is
largely saturated, non-transferrin-bound iron (NTBI)
can be detected (Brissot et al. 2012; de Swart et al.
2016). In contrast to iron bound to transferrin, iron in
NTBI is only loosely bound to molecules such as
citrate, available for redox cycling and, therefore,
considered a toxic iron species (Brissot et al. 2012;
Cabantchik 2014). Nowadays, iron-removal therapies
decrease hepatic and cardiac iron loading mortality
and extend patient’s lives (Adams and Barton 2010;
Adams et al. 1991; Brittenham 2011; Niederau et al.
1996). However, in recent years, kidney function
abnormalities have been arising in patients with b-
thalassemia major (Bhandari and Galanello 2012),
including increased urinary excretion of N-acetyl-D-
glucosaminidase (NAG) and b-2-microglobulin, indi-
cators of renal proximal tubular damage (Aldudak
et al. 2000; Hashemieh et al. 2017; Koliakos et al.
2003; Mohkam et al. 2008; Smolkin et al. 2008;
Sumboonnanonda et al. 1998). Also, renal iron
deposition has been observed in adult patients with
hereditary hemochromatosis (Chmieliauskas et al.
2017; Marble and Bailey 1951; Okumura et al. 2002;
Ozkurt et al. 2014; Rous 1918) or b-thalassemia
syndromes (Hashemieh et al. 2017; Landing et al.
1989; Ong-ajyooth et al. 1998). In vitro studies have
shown that iron exposure can result in decreased
cellular viability in murine and human renal tubular
epithelial cells (Sheerin et al. 1999; Sponsel et al.
1996; Zager and Burkhart 1997). Altogether, these
findings support an association between increased
renal tubular iron exposure and renal tubular injury in
systemic iron overload.
Tubular epithelial cells in the kidney share many
iron handling proteins with other organ systems, such
as transferrin receptor 1 (TfR1), divalent metal
transporters ZIP8 (SLC39A8), ZIP14 (SLC39A14)
and divalent metal transporter 1 (DMT1, SLC11A2),
and iron exporter ferroportin, but their precise cellular
localization and function in renal iron handling remain
uncertain (Martines et al. 2013; Smith and Thevenod
2009; Thevenod and Wolff 2016). Circulating TBI is
suggested to be filtered into the tubular lumen by the
glomerulus (Norden et al. 2001; Zhang et al. 2007).
Subsequently, iron in the tubular lumen has been
reported to be completely reabsorbed by endocytic
transport in renal tubular cells (Thevenod and Wolff
2016). In agreement, hardly any iron is found in urine
of healthy volunteers (Green et al. 1968; Rodriguez
and Diaz 1995). TBI reabsorption has been reported to
mainly take place in proximal tubular epithelial cells
(PTs), facilitated by TfR1 and the megalin–cubilin
receptor complex (Kozyraki et al. 2001; Norden et al.
2001; Ohno et al. 2005; Zhang et al. 2007). After
dissociation from transferrin, iron transport from the
endosome into the cytosol is suggested to involve a
divalent metal transporter. Although not yet clarified
in PTs, studies in other cells suggest a role for ZIP8,
ZIP14 and/or DMT1 in this process (Ji and Kosman
2015; Shindo et al. 2006; Zhao et al. 2010). In the
cytosol, iron is oxidized by H-ferritin and stored in
L-ferritin, may be utilized by iron requiring processes
or exported into the blood stream by the cellular
exporter ferroportin (Thevenod and Wolff 2016).
Tubular NTBI could be directly derived from the
circulation by glomerular filtration or dissociated from
filtered TBI as a result of acidification of the filtrate
passing along the nephron (Martines et al. 2013;
Moulouel et al. 2013; Thevenod and Wolff 2016).
In vitro studies have reported that ZIP8 and ZIP14 are
involved in direct NTBI uptake from the plasma
membrane (Coffey and Knutson 2017; Ji and Kosman
2015; Liuzzi et al. 2006; Pinilla-Tenas et al. 2011;
Wang et al. 2012), but evidence for PTs is lacking.
In this study, we first characterized TBI and NTBI
handling in human conditionally immortalized prox-
imal tubular epithelial cells (ciPTECs). Human
ciPTECs, originating from renal tissue, have previ-
ously been shown to express functional influx and
efflux transporters for solute reabsorption and drug
excretion (Jansen et al. 2014; Wilmer et al. 2010).
Next, we examined the localization of divalent metal
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transporters ZIP8, ZIP14 and DMT1 in these cells, i.e.
at the plasma membrane and/or in endosomes, and
studied the role of ZIP8 and ZIP14 in mediating iron
uptake from NTBI and TBI.
Materials and methods
Cell culture
ciPTECs (clone T1), kindly provided by the depart-
ment of Pharmacology and Toxicology, Radboud
Institute for Molecular Life Sciences, Radboud
University Medical Center, Nijmegen (Jansen et al.
2014), were cultured using DMEM HAM’s F-12
phenol red-free medium (Thermo Fisher Scientific)
containing 5 lg/ml insulin, 5 lg/ml transferrin, 5 ng/
ml selenium, 36 ng/ml hydrocortisone, 10 ng/ml
epithelial growth factor 40 pg/ml tri-iodothyronine
(all Sigma Aldrich), 10% (v/v) fetal calf serum (FCS;
Greiner Bio-one), and 1% (v/v) penicillin–strepto-
mycin (Thermo Fisher Scientific). Cells were cultured
at 33 C and 5% CO2 and maturated for 24 h at 33 C
and 5% CO2 and 7 days at 37 C and 5% CO2 prior to
experiments. Cells were cultured on transwell perme-
able supports to obtain polarization [Corning Tran-
swell, coated with 50 lg/ml collagen VI (both Sigma
Aldrich)] for ZIP8, ZIP14, DMT1 and ferroportin
immunostaining, 55Fe transport and Alexa Fluor
546-conjugated human holotransferrin (Alexa546-
Transferrin, Thermo Fisher Scientific) uptake studies.
Transepithelial electrical resistance (TEER) measure-
ments and FITC-inulin permeability analysis were
performed as previously described (Jansen et al.
2014).
Iron exposure
To simulate NTBI exposure, cells were exposed to
0–500 lM ferric citrate (FeC, Sigma Aldrich). FeC
was dissolved overnight in MQ water at 37 C and
added to medium devoid of FCS. Cell pellets were
collected and stored at - 80 C prior to iron assess-
ment or immunoblotting. For TBI uptake studies, cells
were depleted of transferrin by incubation in DMEM
HAM’s F-12 mediumwithout supplements for 2 h and
exposed to 25 lg/ml Alexa546-Transferrin for
30 min. In iron loading conditions, cells were instead
exposed to 100 lM FeC and 100 lg/ml holo-
transferrin (Sigma Aldrich) for 2 h and subsequently
exposed to Alexa546-Transferrin. Afterwards, cells
were used for immunostaining as described below. To
simulate iron overload exposure, cells were exposed to
100 lM FeC in medium supplemented with FCS for
48 h and used for immunostaining of ZIP8 and ZIP14.
Small interfering RNAs (siRNAs)
Cells were seeded at 20% confluency and transfected
on two consecutive days with 50 pmol (ZIP8, ZIP14)
or 100 pmol (ferroportin) small interfering RNAs
(siRNAs) (ON-TARGETplus SMARTpool siRNAs
for SLC39A8, SLC39A14, SLC40A1 and non-target-
ing pool as scrambled control, Dharmacon) and 5 ll
oligofectamine in Opti-MEM (both Thermo Fisher
Scientific). After 4 h, fresh medium was added. Cells
were analyzed 48 h after the second transfection.
Protein isolation and immunoblotting
Proteins were isolated using RIPA buffer [0.15 M
NaCl, 0.012 M Sodium Deoxycholate, 1% NP40,
0.1% SDS, 0.05 M Tris, pH 7.5, freshly supplemented
with protease inhibitors (Roche Complete Mini,
Roche)]. Protein concentration was determined using
the Pierce BCA assay kit according to the manufac-
turer’s instructions (Thermo Fisher Scientific). Protein
samples were prepared in loading buffer, separated on
SDS-PAGE gels, transferred to a nitrocellulose or
PVDF membrane and incubated with primary anti-
body overnight at 4 C. After 1 h incubation at RT
with secondary antibody, proteins were visualized on
an Odyssey fluorescence scanner (total ferritin, b-
actin) or LAS-3000 scanner for chemiluminescence
(all other primary antibodies). Antibodies and dilu-
tions are summarized in Online Resource 1.
Cell surface biotinylation
Cells were biotinylated with 0.5 mg/ml Sulfo-NHS-
LC-LC-biotin (Thermo Fisher Scientific) for 30 min at
4 C with gentle shaking. Protein lysates were
collected by scraping and incubated overnight with
Neutravidin beads (Thermo Fisher Scientific) to
isolate cell surface biotinylated proteins. After eluting
cell surface proteins from the beads in Laemmli buffer
(Biorad) supplemented with 50 mM DTT for 30 min
at 37 C, proteins were directly used for
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immunoblotting since the Pierce BCA assay could not
be applied in this buffer solution. Therefore, both
membrane protein and total lysate protein fraction
were loaded on SDS-PAGE gels to obtain comparable
Na K ATPase bands and allow comparison of proteins
of interest between the two fractions.
RNA isolation and quantitative PCR
RNA isolation was performed using TRIzol (Thermo
Fisher Scientific) according to the manufacturer’s
instructions. A reverse transcription reaction was
performed with 1 lg RNA, 4 ll first strand buffer,
1 ll dNTPs (12.5 mM), 2.04 ll random primers, 2 ll
DDT, 1 ll M-MLV (all Thermo Scientific) and 0.5 ll
RNAsin (Promega Corporation). The PCR cycle
consisted of 10 min at 20 C, 45 min at 42 C and
10 min at 95 C. Quantitative PCR was performed on
a CFX96 (Bio-rad) using 4 ll cDNA (10 ng/ml), 10 ll
SYBR Green Power master mix (Applied Biosystems)
and 6 ll primer mix (containing 1 lM forward primer
and reverse primer). The PCR protocol was as follows:
7 min at 95 C, 40 cycles of 15 s at 95 C and 1 min at
60 C, and 10 min at 95 C, with a measurement at the
end of each cycle. Fold change values were calculated
using the DDCt formula. Primers are summarized in
Online Resource 2.
Immunofluorescent staining
Cells seeded on coverslips or transwell supports were
fixed with 4% paraformaldehyde or 2% paraformalde-
hyde supplemented with 4% sucrose, permeabilized
with 0.5% Triton X-100, 0.2% Tween-20 or 1% SDS
and incubated with primary antibody overnight at
4 C. Subsequently, cells were stained with fluores-
cent secondary antibody for 1 h at RT and counter-
stained with DAPI (40,6-diamidino-2-phenylindole,
300 lM, Thermo Fisher Scientific). Images were
taken using the Zeiss S/N 3834004266 or confocal
Olympus FV1000. Co-stainings were performed for
TfR1, ZIP8, ZIP14 and DMT1 with early endosome
antigen 1 (EEA1). Antibodies are summarized in
Online Resource 1.
Iron assessment
Intracellular iron levels were determined using the
chromogen bathophenanthroline as described (Torrance
and Bothwell 1968). Iron concentrations were calculated
by comparison to a standard curve of ferrous sulphate
and corrected for protein concentration.
55Fe transport
Cells were incubated with 0.2 lM 55FeCl3 (Perkin
Elmer) in a mixture with 100 lM FeC and 1 mM
ascorbic acid (Sigma Aldrich) in Krebs–Henseleit-
HEPES (KH-H) buffer supplemented with 2.5 mM
CaCl22H2O, 25 mM NaHCO3 and 10 mM HEPES
pH 7.4 (Sigma Aldrich). For cells grown in transwell
supports, cells were depleted of iron in DMEM
HAM’s F-12 medium without supplements for 2 h
and incubated with 55Fe in KH-H in the apical
compartment or in medium in the basolateral com-
partment for 8 h at 37 C. For ZIP8 and ZIP14 siRNA
experiments, cells were depleted of iron in KH-H
buffer for 2 h and incubated with 55Fe for 30 min
afterwards. For ferroportin siRNAs, cells were
exposed to 55Fe for 2 h. Subsequently, cells were
washed with ice-cold KH-H and harvested using RIPA
buffer. Afterwards, radioactivity was measured using
liquid scintillation counting. Radioactivity in protein
pellets was corrected for protein concentration.
55Fe-TBI was prepared by incubating apo-transfer-
rin (Sigma Aldrich) with 7.5 nmol 55FeCl3 and
75 nmol sodium citrate in KH-H for 1 h at RT.
Unbound iron was removed by repeated washing in
30 KAmicon filter units. After iron depletion in KH-H
buffer for 2 h, cells were exposed to 2 lM 55Fe-TBI
for 4 h and analyzed as described above.
Statistical analysis
Data were statistically analyzed using GraphPad Prism
and presented as mean ± SEM. Results were ana-
lyzed by one-way ANOVA with Dunnett’s post test or
Student’s t test where appropriate. Differences were
considered statistically significant when p\ 0.05.
Results
Characterization ciPTEC model for studying iron
handling
We first characterized the presence and abundance of
known iron handling proteins in ciPTECs in
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unstimulated conditions and after iron exposure. Upon
exposure to NTBI (FeC), ciPTECs showed a time-
dependent increase in intracellular iron levels, which
was statistically significant for 100 and 200 lM FeC
after exposure for 16 and 24 h (Fig. 1a). This was
complemented by increased total ferritin and
decreased TfR1 protein levels compared to control
(Fig. 1b), confirming genomic iron responsive ele-
ment – iron responsive protein (IRE-IRP) regulation of
these proteins in ciPTECs (Muckenthaler et al. 2017).
Next, we examined iron uptake in polarized ciPTECs,
grown on transwell supports. Monolayer integrity was
confirmed by minimal paracellular permeability of the
diffusion marker FITC-inulin (7.6 ± 0.8 pmol/min/
cm2), appropriate transepithelial electric resistance
(TEER; C 140 X/cm2) and clear expression of the
tight junction protein zona occludens 1 (ZO-1;
Fig. 1c) (Jansen et al. 2014). In ciPTECs cultured on
transwell supports, apical 55Fe exposure resulted in
intracellular iron loading while basolateral 55Fe
exposure showed only limited cellular uptake
(Fig. 1d). This indicates that ciPTECs take up iron
Fig. 1 Uptake of non-transferrin-bound iron and transferrin-
bound iron in ciPTECs. Intracellular iron concentration (a), total
ferritin and transferrin receptor 1 (TfR1) protein levels (b) in
ciPTECs after incubation with different concentrations of ferric
citrate (NTBI). Zona occludens 1 (ZO-1) immunostaining (in
green) confirming monolayer integrity in polarized ciPTECs.
ZO-1 tight junctions indicated by arrows (c). 55Fe content in
apical compartment, basolateral compartment and cell lysate
after 55Fe exposure from the apical (A to BL) or basolateral (BL
to A) cellular side (d). Alexa546-Transferrin (546Tf, in red)
internalization alone, combined with holo-transferrin (Holo-Tf)
or at 4 C (e). 546Tf internalization in iron deplete or iron
replete conditions, from apical or basolateral cellular side (f).
Nuclei counterstained with DAPI (in blue). Representative
images and graphs showing mean of three independent
experiments for each time point or FeC concentration except
n = 6 for panel c. Scale bar 5 lM. One-way ANOVA with
Dunnett’s post test compared to control at each time point was
used in a; *p\ 0.05; **p\ 0.01; ***p\ 0.001. (Color
figure online)
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mainly from the apical cellular side. Additionally, we
characterized the direction of iron export in ciPTECs.
Polarized ciPTECs showed basolateral iron export
after apical 55Fe exposure, while basolateral 55Fe
exposure showed negligible apical iron export
(Fig. 1d). CiPTECs also demonstrated uptake of
Alexa546-Transferrin (holo-transferrin), which was
diminished in combination with unlabelled holo-
transferrin, indicating ligand-specific competition, or
at 4 C, suggesting active uptake (Fig. 1e). Alexa546-
Transferrin uptake was mostly observed after apical
exposure, and little uptake was seen after basolateral
exposure, whereas both apical and basolateral uptake
was reduced in iron-loaded cells (Fig. 1f). The latter
suggests that ciPTECs regulate TBI uptake based on
intracellular iron levels through IRE-IRP regulation.
We further investigated the role of ferroportin in
iron export observed in ciPTECs. Ferroportin
immunostaining showed localization near the baso-
lateral cellular side (Fig. 2a), in agreement with its
presumed role in iron export in PTs to the plasma
(Drakesmith et al. 2015). To study the functional
contribution of ferroportin to iron export, we used
siRNA technology. Successful ferroportin knockdown
was confirmed on mRNA level (p\ 0.001, Fig. 2b).
Ferroportin knockdown increased cellular 55Fe con-
tent compared to scrambled control, while 55Fe in the
exposure solution was decreased (p\ 0.05 and
p\ 0.01, respectively, Fig. 2c). This was comple-
mented by increased total ferritin protein levels and a
trend of decreased TfR1 mRNA levels in ferroportin
knockdown compared to control (Fig. 2d). These data
confirm that ferroportin functions as an iron exporter
in ciPTECs at the basolateral membrane.
NTBI uptake involves ZIP8 and ZIP14
To investigate whether ZIP8 and ZIP14 could mediate
apical NTBI uptake, we examined their localization in
ciPTECs. We found ZIP8 and ZIP14 immunostaining
near the apical cellular side in ciPTECs cultured on
transwell supports (Fig. 3a). We applied cell surface
biotinylation and subsequent immunoblotting to
investigate the localisation of these transporters at
the plasma membrane and/or in intracellular endo-
somes. Succesful membrane isolation was confirmed
by the presence of plasma membrane marker Na K
ATPase in the cell surface fractions, whereas the
endosomal marker EEA1 and cytosolic protein b-actin
were absent compared to the total cell fractions
(Fig. 3b). We detected both ZIP8 and ZIP14 in the
ciPTEC plasma membrane and total cell lysate
fraction. In contrast, DMT1 immunostaining was
detected near the apical membrane, but we did not
detect this protein in cell surface fractions (Fig. 3a, b).
This indicates ZIP8 and ZIP14 are potential candidates
for NTBI uptake at the plasma membrane and
subsequent experiments have, therefore, focused on
ZIP8 and ZIP14.
We applied ZIP8 and ZIP14 siRNA technology to
knockdown each transporter on mRNA level (60%
ZIP8 and 60% ZIP14 mRNA remaining compared to
scrambled control; p\ 0.001), without affecting
mRNA expression of the other ZIP transporter
(ZIP14 and ZIP8, respectively) (Fig. 4a, b). Protein
expression was decreased to 50% of scrambled control
for ZIP8 and 60% for ZIP14 (Fig. 4a, b). However,
silencing of either ZIP8 or ZIP14 did not significantly
reduce 55Fe uptake (85% and 95% of scrambled
control, respectively, Fig. 4c, d). Since both trans-
porters are described to have similar iron transport
capacities (Jenkitkasemwong et al. 2012), we also
applied combined siRNA knockdown. Both trans-
porters were successfully downregulated on mRNA
and protein level (50% ZIP8 and 40% ZIP14 mRNA,
and 50% ZIP8 and 50% ZIP14 protein remaining,
respectively; Fig. 4e). Knockdown of both trans-
porters significantly reduced 55Fe uptake (70% of
control, p\ 0.05, Fig. 4f). This indicates that both
ZIP8 and ZIP14 play a role in NTBI uptake and indeed
show redundancy in ciPTECs.
TBI-derived iron uptake involves ZIP14
We detected TfR1 near the ciPTEC apical membrane
using fluorescent immunostaining (Fig. 5a) and found
TfR1 to colocalize with both EEA1 and Alexa546-
Transferrin (Fig. 5b, c), indicating TBI uptake
involves TfR1 via endocytosis. Subsequently, we
examined whether ZIP8 and ZIP14 may play a role in
iron uptake resulting from TBI endocytosis. We found
only ZIP14, but not ZIP8, to colocalize with EEA1
(Fig. 6a), suggesting a possible involvement of ZIP14
in transport of iron out of the endosome towards the
cytosol. This staining pattern was not affected by iron
exposure (Fig. 6b), indicating ZIP8 is absent from
ciPTEC endosomes independent of cellular iron
status. ZIP14 immunostaining colocalized with
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Alexa546-Transferrin uptake (Fig. 6c), but ZIP14
knockdown did not affect Alexa546-Transferrin
uptake (Fig. 6d). Cellular 55Fe content, however,
was decreased in ZIP14 knockdown cells compared
to control after 55Fe-TBI exposure (p\ 0.05, Fig. 6e).
This indicates ZIP14 could be involved in TBI-derived
iron uptake. DMT1 was also found to colocalize with
EEA1 immunostaining (Fig. 6f) and, even though
DMT1 mRNA expression did not change with ZIP14
knockdown (Fig. 6g), ZIP14 and DMT1 could be
redundant in TBI-derived iron uptake.
Discussion
Evidence of renal complications in patients with
systemic iron overload is accumulating, while the
molecular mechanisms of renal NTBI and TBI han-
dling in systemic iron overload remain unclear. We
have shown that human PTs take up both NTBI and
TBI. NTBI uptake involves both ZIP8 and ZIP14,
which demonstrate redundancy. In contrast, TBI
uptake is mediated by TfR1 endocytosis, where
ZIP14, but not ZIP8, may be involved in iron release
from the endosome into the cytosol (Fig. 7).
In addition to studies that report the suitability of
ciPTECs to study renal physiology (Jansen et al. 2014;
Wilmer et al. 2010), we have demonstrated that this
model is also qualified to study renal PT iron handling
Fig. 2 Ferroportin-
mediated iron export in
ciPTECs. Ferroportin
immunostaining (in green)
in polarized ciPTECs (a).
Nuclei counterstained with
DAPI (in blue). Confocal
images taken in x–y and y–z
axis showing apical (A) and
basolateral (BL) cellular
side. CiPTEC ferroportin
mRNA expression (b), pmol
55Fe in cell lysate or solution
(c), total ferritin protein
expression and transferrin
receptor 1 (TfR1) mRNA
expression (d) after
transfection with scrambled
control (Scr) or ferroportin
(FPN1) small interfering
RNAs (siRNA).
Representative images and
graphs showing mean of at
least three independent
experiments (a, n = 3; b,
n = 9; c, n = 4; d, both
n = 3). Scale bar 5 lM.
Student’s t-test was used in
b, c and d; *p\ 0.05;
**p\ 0.01. (Color
figure online)
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as it contains mechanisms for iron uptake, intracellular
handling and export. Using this model, we newly
demonstrated the subcellular distribution of endoge-
nous ZIP8 and ZIP14 in human PTs using cell surface
biotinylation, immunoblotting and immunofluorescent
colocalization stainings, which extends previous stud-
ies that mostly relied on overexpression models
(Thevenod and Wolff 2016). Our results show vari-
ability in divalent iron transporter localization in PT
cells in terms of their localization at the plasma
membrane or at the endosomal membrane. NTBI
exposure was experimentally approached by addition
of FeC to serum-free medium, preventing TBI forma-
tion, but allowing formation of citrate-bound NTBI.
Interestingly, we observed a difference in involvement
of ZIP8 and ZIP14 in NTBI and TBI uptake by
ciPTECs. Although siRNA silencing in ciPTECs was
limited, i.e. silencing of* 50% was achieved for all
examined proteins, including ZIP8, ZIP14, ferroportin
and ZIP8 and ZIP14 combined, it nevertheless
demonstrated that both ZIP8 and ZIP14 were involved
in NTBI uptake, whereas only ZIP14 may play a role
in TBI-derived iron uptake. These observations sup-
port the notion that we studied uptake of two distinct
Fig. 3 Presence of ZIP8, ZIP14 and DMT1 in ciPTECs. ZIP8,
ZIP14 and divalent metal transporter 1 (DMT1) immunostain-
ing (in green) in polarized ciPTECs. Nuclei counterstained with
DAPI (in blue). Confocal images taken in x–y and y–z axis
showing apical (A) and basolateral (BL) cellular side (a). Cell
surface biotinylation and immunoblotting of ZIP8, ZIP14 and
DMT1 in both membrane fraction and total lysate fraction. In
addition, Na K ATPase was used as positive control for cellular
membrane proteins, early endosome antigen 1 (EEA1) as
negative control for endosomal proteins and b-actin as negative
control for cytosolic proteins. Similar Na K ATPase protein
levels were loaded in both membrane fraction and total lysate
fraction. Prolonged chemiluminescence confirmed depicted
findings (data not shown) (b). Representative images showing
three independent experiments. Scale bar 5 lM. (Color
figure online)
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Fig. 4 ZIP8 and ZIP14 mediate NTBI uptake in ciPTECs. ZIP8
and ZIP14mRNA and protein expression after transfection with
scrambled control (Scr) and either ZIP8 (a) or ZIP14 small
interfering RNA (siRNA) (b). Pmol 55Fe uptake in cell lysate
after either ZIP8 (c) or ZIP14 siRNA transfection (d). ZIP8 and
ZIP14 mRNA and protein expression (e) and pmol 55Fe uptake
in cell lysate (f) after transfection with scrambled control or
combined ZIP8 ? ZIP14 siRNAs. Representative graphs.
Number of experiments depicted in each panel. Student’s t-test
was used in a–e; *p\ 0.05; ***p\ 0.001
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iron species. ZIP8 and ZIP14 were both present at the
ciPTEC plasma membrane and showed redundancy in
tubular NTBI import. This redundancy for plasma
membrane NTBI uptake is likely since both ZIP8 and
ZIP14 are reported to transport iron together with
HCO3
- at pH 6.5–7.5 (He et al. 2006; Pinilla-Tenas
et al. 2011;Wang et al. 2012; Zhao et al. 2010). Also in
hereditary hemochromatosis mouse models lacking
ZIP14, NTBI uptake in the kidney was still detected,
further corroborating redundancy of iron transporters
(Jenkitkasemwong et al. 2015). Besides ZIP8 and
ZIP14, other mechanisms for NTBI uptake have been
described in various organs, which could explain why
even the combined silencing of ZIP8 and ZIP14 did
not abolish NTBI uptake in our model. In human
hepatocytes, DMT1 was detected at the plasma
membrane and was found to mediate NTBI uptake in
these cells (Shindo et al. 2006). Although we previ-
ously detected DMT1 in human PTs (van Raaij et al.
2018), it was not present at the plasma membrane in
ciPTECs. As a result, we believed that a role for
DMT1 in direct NTBI uptake at the plasma membrane
was unlikely and focussed our studies on ZIP8 and
ZIP14. Furthermore, in the circulation, NTBI can be
bound to albumin (Silva and Hider 2009) and, as such,
be reabsorbed in the PT by the multiligand megalin–
cubilin receptor complex (Christensen et al. 2012).
Alternatively, L-type voltage-dependent calcium
Fig. 5 Transferrin receptor 1 mediates Alexa546-Transferrin
uptake in ciPTECs. Transferrin receptor 1 (TfR1) immunos-
taining (in green) in polarized ciPTECs (a). TfR1 immunos-
taining (in green) colocalization with Alexa546-Transferrin
(546Tf) internalization (in red) (b) or early endosome antigen 1
(EEA1) immunostaining (in red) (c). Nuclei counterstained with
DAPI (in blue). Confocal images taken in x–y and y–z axis
showing apical (A) and basolateral (BL) cellular side. Repre-
sentative images of three experiments. Scale bar 5 lM. (Color
figure online)
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Fig. 6 ZIP14 mediates
Alexa546-Transferrin
uptake in ciPTECs. Double
immunostaining of ZIP8 or
ZIP14 (in green) and early
endosome antigen 1 (EEA1,
in red) in unstimulated
conditions (a) or after 48 h
iron overload exposure (b).
ZIP14 immunostaining (in
green) colocalization with
Alexa546-Transferrin
(546Tf) internalization (in
red) (c). 546Tf
internalization (d) or pmol
55Fe in cell lysate after 55Fe-
TBI exposure (e) after
transfection with scrambled
control or ZIP14 small
interfering RNA (siRNA).
Double immunostaining of
divalent metal transporter 1
(DMT1, in green) and EEA1
(in red) (f). DMT1 mRNA
expression (g) after
transfection with ZIP14 or
scrambled control siRNAs.
Nuclei counterstained with
DAPI (in blue). Confocal
images show x–y and y–z
axis. Representative images
and graphs of three
experiments. Scale bar
5 lM. Student’s t-test was
used in e, g; *p\ 0.05.
(Color figure online)
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channels have been reported to facilitate NTBI uptake
in cardiomyocytes (Oudit et al. 2003; Oudit et al.
2006), which may also be the case in the human
kidney, as these channels have been demonstrated in
rat kidney (Zhao et al. 2002).
We showed that TBI is internalized predominantly
from the apical cellular side and this is mediated by the
endocytic transporter TfR1. In addition, also the
megalin–cubilin receptor complex is reported to take
up TBI in PTs (Kozyraki et al. 2001). The fact that TBI
uptake was reduced during iron loading implies IRE-
IRP-regulated restriction of TBI uptake, hence sug-
gesting that TBI uptake in PTs is predominantly
mediated through TfR1. Moreover, TfR1 reduction in
iron excess conditions suggests that TBI uptake is not
the major cause of PT iron accumulation during iron
overload. Since ZIP8 and ZIP14 abundance is not
controlled by IRE-IRP regulation (Jenkitkasemwong
et al. 2012), it is plausible that especially unrestricted
tubular NTBI uptake by these proteins results in renal
iron loading and potentially subsequent iron-mediated
kidney injury during systemic iron overload.
In ciPTECs, ZIP14 may play a role in transport of
iron from the endosome towards the cytosol. In the
endosome, ferric iron is released from transferrin, and,
subsequently, reduced to ferrous iron, possibly by a
STEAP protein or Prion protein, which have been
found in human and mouse kidney, respectively
(Ohgami et al. 2005, 2006; Tripathi et al. 2015). Iron
is found to dissociate from transferrin in early
endosomes at pH 6.5 (Nunez et al. 1990), and ZIP14
is shown to transport iron at a similar pH (Pinilla-
Tenas et al. 2011; Zhao et al. 2010). Furthermore,
ZIP14 is shown to mediate iron uptake from TBI in
hepatocytes (Zhao et al. 2010), while both ZIP8 and
ZIP14 are found to mediate iron uptake from TBI
uptake in neurons (Ji and Kosman 2015). Our results
support the novel conclusion that ZIP14, but not ZIP8,
may be involved in TBI-derived iron uptake in PT
early endosomes. Our data do not substantiate the
presence of ZIP8 in endosomes, which was shown for
overexpressed rat ZIP8 in HEK293 cells (Wang et al.
2012). However, TBI-derived iron uptake was not
abolished with ZIP14 knockdown. Indeed, renal iron
Fig. 7 Proposed NTBI and TBI handling in proximal tubular
epithelial cells. Non-transferrin-bound iron (NTBI) and trans-
ferrin-bound iron (TBI) present in the systemic circulation are
filtered by the glomerulus into the tubular lumen and are
subsequently reabsorbed by proximal tubular cells. NTBI
uptake at the plasma membrane involves both ZIP8 and ZIP14
that show redundancy. TBI uptake involves TfR1-mediated
endocytosis. Subsequently, iron is transported from the endo-
some towards the cytosol via ZIP14 and potentially also divalent
metal transporter 1 (DMT1). Once in the cytosol, in the labile
iron pool, iron is utilized, stored in ferritin or exported back into
the circulation by ferroportin at the basolateral membrane.
(Color figure online)
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loading was observed in several hereditary hemochro-
matosis mouse models with TBI exposure despite
ZIP14 knockout (Jenkitkasemwong et al. 2015).
Besides ZIP14, we detected DMT1 in endosomes in
ciPTECs and, therefore, DMT1 is a potential candi-
date for endocytic iron transport in PTs, like is
reported in hepatocytes (Gunshin et al. 1997; Tabuchi
et al. 2000; Wang and Knutson 2013). DMT1 is shown
to transport iron at pH 5.5 (Gunshin et al. 1997).
Therefore, it is possible that DMT1 transports iron into
the cytosol from late endosomes, which are charac-
terized by a pH between 4.5 and 5.5 (Pinilla-Tenas
et al. 2011), in PTs, and this is an interesting topic for
future studies (in ciPTECs). Moreover, also TRPML1
(mucolipin1) is reported to transport iron in late
endosomes or early lysosomes (Dong et al. 2008). The
importance of this transporter in endosomal iron
uptake is illustrated by findings of decreased cytosolic
iron levels in TRPML1 knockout fibroblasts, and iron-
deficiency and anaemia in patients with TRPML1
mutations (Altarescu et al. 2002; Dong et al. 2008).
TRPML1 has also been found in the kidney and could,
thus, mediate endosomal iron transport into the cytosol
(Cheng et al. 2010; Philpott et al. 2017; Thevenod and
Wolff 2016).
Although ZIP8 and ZIP14 demonstrated redun-
dancy in ciPTEC NTBI transport, differential func-
tions for both transporters have been reported. Despite
similar iron transport capacities (Jenkitkasemwong
et al. 2012), ZIP8 and ZIP14 show a different
localization pattern at the organ level, suggesting that
these transporters have different roles in NTBI uptake
from the circulation.While ZIP14 has been reported as
the main NTBI uptake transporter in the liver and
pancreas (Jenkitkasemwong et al. 2015), ZIP8 is
implicated to be the major NTBI transporter in
hippocampal neurons (Ji and Kosman 2015). As such,
mutations in ZIP8 and ZIP14 in patients both lead to
changes in metal transport, but show distinct pheno-
types (Boycott et al. 2015; Li et al. 2016; Park et al.
2015; Tuschl et al. 2016). In addition to PTs, ZIP8 and
ZIP14 are also present in human distal tubular
epithelial cells (Ajjimaporn et al. 2012; van Raaij
et al. 2018), but it remains to be investigated to what
extent both transporters are involved in NTBI han-
dling in the distal nephron.
In our current study in human ciPTECs, we
observed ferroportin expression at the basolateral side
of the cell, whereas expression at the apical and
basolateral membrane was reported previously in
murine PT (Moulouel et al. 2013; Starzynski et al.
2013; Veuthey et al. 2008; Wolff et al. 2011; Zarjou
et al. 2013). We recently showed ferroportin expres-
sion in human kidney biopsies also at the basolateral
cellular side (van Raaij et al. 2018). Moreover, our
findings in ciPTECs show that ferroportin functioned
solely as iron exporter, and not as iron importer as has
previously been suggested (Zarjou et al. 2013). Our
results are in line with the general belief of a
ferroportin cellular iron export function (Nemeth
et al. 2004). Since to date no other iron cellular iron
exporters have been identified, ferroportin is essential
for physiological renal iron handling. Moreover,
reabsorption of filtered iron and export back into the
systemic circulation is crucial for maintaining ade-
quate body iron levels as well as preventing intracel-
lular renal iron loading and potential iron-induced
renal toxicity.
In summary, our findings in human ciPTECs show
that ZIP8 and ZIP14 are involved in TBI and NTBI
uptake. Nevertheless, the results also demonstrate high
redundancy in divalent metal transport in ciPTECs,
suggesting complex mechanisms of iron uptake.
Future studies should be aimed at elucidating the
apparent complex process of proximal tubular iron
reabsorption to further assess the contribution of
individual transporters to iron uptake in physiological
conditions and during systemic iron overload.
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